Matthew J Byerly Selected Research

Biomarkers (Surrogate Marker)

1/2017

A resting EEG study of neocortical hyperexcitability and altered functional connectivity in fragile X syndrome.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Matthew J Byerly Research Topics

Disease

18	Schizophrenia (Dementia Praecox) 01/2020 - 01/2003
13	Psychotic Disorders (Schizoaffective Disorder) 01/2020 - 08/2005
1	Neurodevelopmental Disorders 01/2017
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 05/2013
1	Coronary Disease (Coronary Heart Disease) 05/2013
1	Cardiovascular Diseases (Cardiovascular Disease) 05/2013
1	Major Depressive Disorder (Major Depressive Disorders) 10/2010
1	Hyperprolactinemia 02/2009

Drug/Important Bio-Agent (IBA)

13	Antipsychotic Agents (Antipsychotics)IBA 01/2020 - 01/2003
7	Risperidone (Risperdal Consta)FDA LinkGeneric 05/2013 - 05/2003
6	Quetiapine Fumarate (Seroquel)FDA Link 05/2013 - 10/2004
5	Olanzapine (Zyprexa)FDA Link 05/2013 - 05/2003
2	Aripiprazole (Abilify)FDA Link 05/2013 - 02/2009
2	ProlactinIBA 02/2009 - 05/2007
1	Biomarkers (Surrogate Marker)IBA 01/2017
1	haloperidol decanoate FDA LinkGeneric 10/2016
1	Paliperidone Palmitate FDA Link 10/2016
1	Antidepressive Agents (Antidepressants)IBA 10/2010
1	Fluoxetine (Prozac)FDA LinkGeneric 10/2010

Therapy/Procedure

2	Injections 01/2020 - 10/2016
1	Therapeutics 08/2005